IMMUNITYBIO, INC. INVESTORS WITH LOSSES HAVE UNTIL MAY 26, 2026 TO JOIN SECURITIES CLASS ACTION – Bernstein Liebhard LLP Announces Deadline

NEW YORK, May 20, 2026 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP, a nationally acclaimed investor rights law firm, reminds ImmunityBio, Inc. (“ImmunityBio” or the “Company”) (NASDAQ: IBRX) investors of the  May 26, 2026 deadline involving a securities fraud class action lawsuit commenced against the Company. Should You Join The ImmunityBio Class Action Lawsuit : Do you, or did you, own shares of ImmunityBio, Inc. (NASDAQ: IBRX)?